DeNovX is ...
an innovative life sciences company with crystallization methods that accelerate pharmaceutical development and make drug manufacturing more productive.
Over 90% of pharmaceuticals contain crystalline materials, and control of the physical properties of these crystals is important to drug development, production, and use. Our patented crystallization products and continuous manufacturing technologies help innovator pharmaceutical companies, generics manufacturers, contract research Organizations (CROs), and R&D teams overcome the challenges of crystal form control.
Think Forward - to rational crystal screening and solid form controls.
Control of the size, shape, and structure of crystalline pharmaceutical components remains a challenge for R&D and production.
Screening with crystallization platforms based on self assembled monolayers (SAMs) is fast and mass efficient.
Work with us to explore continuous crystallization processes that replace costly batch methods and give better control of crystal size distribution.